Questionnaire
Otherquestionnaire
NCT Number: NCT04034875
The incidence of aggression and violent behavior is usually reported to be high after acquired brain injury, around 54%. Behaviors with verbal agression and, less frequently, physical agressions, are described.
These behaviors may be linked to the dysfunction of the frontal lobes responsible for executive functions and complex social interactions, or to the dysfunction of the temporal structures that may also be responsible for increased aggression.
It is interesting to note that very few scales or specific questionnaires evaluate the factors and co-variables that could lead to aggressive behavior after an acquired brain injury. Such questionnaires are very rare, and none have been validated in French.
The objective of this study is to develop a questionnaire in French that aims to assess anger, hostility and aggression after acquired brain injury. The psychometric qualities of this questionnaire will be evaluated using the Rasch probabilistic model.
The development of such a tool will be of major interest for clinical practice and future clinical research.
Looking for future studies?
Notify Me18 year–75 year
All sexes
Interventional
Not applicable
Brugmann University Hospital, Brussels, Belgium
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
questionnaire
Time frame: 30 minutes
questionnaire validity
Brugmann University Hospital
Other
SOCIALBI, a Rasch Questionnaire for the Evaluation of Anger, Hostility and Aggression After Acquired Brain Injury.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03731104
Arterial Hypotension, Cardiovascular Diseases
Paris, France
View Trial DetailsNCT04639401
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Melsbroek, Belgium
View Trial DetailsNCT03114904
Cerebral Lesion, Chemically-Induced Disorders
Amiens, Picardie, France
View Trial DetailsNCT05922748
Cerebral Lesion, Cognition Disorders
Paris, Île-de-France Region, France
View Trial Details